DURVAXITY

Welcome to the Brand page for “DURVAXITY”, which is offered here for Vaccine adjuvants; drug carriers for medical use, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals;chemical and biological reagents for use in the manufacture of pharmaceuticals, for use in the manufacture of pharmaceutical preparations containing messenger rna (mrna) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use;medical services; medical information; providing a website featuring medical information;pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines;.

Its status is currently believed to be active. Its class is unavailable. “DURVAXITY” is believed to be currently owned by “Seqirus Inc.”